Ocular Therapeutix Newsroom

Press Release: Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dow JonesJul 18 16:05 ET

Ocular Therapeutix (OCUL) Gets a Buy From Piper Sandler

TipRanksJul 17 12:11 ET

Investors Await Earnings Reports, Tech Stocks Take Hit as US Futures Fall Sharply Pre-Bell

MT NewswiresJul 17 08:08 ET

Institutional Investors Have a Lot Riding on Ocular Therapeutix, Inc. (NASDAQ:OCUL) With 64% Ownership

Simply Wall StJul 14 10:01 ET

The One-year Returns Have Been Notable for Ocular Therapeutix (NASDAQ:OCUL) Shareholders Despite Underlying Losses Increasing

Yahoo FinanceJul 12 08:07 ET

Piper Sandler Sticks to Their Buy Rating for Ocular Therapeutix (OCUL)

TipRanksJul 12 06:37 ET

Ocular Therapeutix Announces Late-Breaking Abstract of HELIOS Study to Be Presented at 42nd ASRS Annual Scientific Meeting

Yahoo FinanceJul 10 08:00 ET

Form 144 | Ocular Therapeutix(OCUL.US) Officer Proposes to Sell 251.9K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 9, $Ocular Therapeutix(OCUL.US)$ Officer RABIA OZDEN intends to sell 38,437 shares of its common stock on Jul 9, with a total market value of approximately $251.9K.

Moomoo NewsJul 9 16:27 ET

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo FinanceJul 8 16:05 ET

Ocular Therapeutix Insiders Sell US$577k Of Stock, Possibly Signalling Caution

Simply Wall StJun 23 08:46 ET

Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsJun 21 07:32 ET · Ratings

Ocular Therapeutix Jumps as TD Cowen Upgrades to Buy and Hikes PT

Seeking AlphaJun 20 14:24 ET

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

BenzingaJun 20 13:26 ET

KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday

BenzingaJun 20 10:21 ET

This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

BenzingaJun 20 09:13 ET

Express News | Ocular Therapeutics Shares Are Trading Higher After TD Cowen Upgraded the Stock From Hold to Buy and Raised Its Price Target From $7 to $11

BenzingaJun 20 07:26 ET

TD Cowen Upgrades Ocular Therapeutix(OCUL.US) to Buy Rating, Raises Target Price to $11

moomoo NewsJun 20 06:31 ET · Ratings

Express News | Ocular Therapeutix up 7.5% Premarket After TD Cowen Raises to Buy From Hold, Hikes PT

ReutersJun 20 05:53 ET

Express News | Ocular Therapeutix Inc : TD Cowen Raises Target Price to $11 From $7

ReutersJun 20 05:43 ET

Express News | Ocular Therapeutix Inc : TD Cowen Raises to Buy From Hold

ReutersJun 20 05:43 ET